Healthcare – Page 17

Newswire

[ September 15, 2025 ] “Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP) CEO Interview
[ September 15, 2025 ] Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business CEO Interview
[ September 15, 2025 ] NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market CEO Interview
[ September 15, 2025 ] Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL! Aerospace & Defense
[ September 15, 2025 ] Next Super Stock (NASDAQ: ADN) Hydrogen Fuel Cell Tech: Future of ENERGY $100 Billion Opportunity! Aerospace & Defense
[ September 15, 2025 ] (NASDAQ: HOTH) Advances Biotech Portfolio w Multiple Catalysts for 10X Upside Potential CEO Interview
[ September 10, 2025 ] Advent Technologies (NASDAQ: ADN) Announces Major Milestone in its Strategic Collaboration with Airbus Newsmakers
[ September 10, 2025 ] Hoth Therapeutics (NASDAQ: HOTH) Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities Newsmakers
[ September 10, 2025 ] Worksport (NASDAQ: WKSP) Posts Fourth Consecutive Monthly Sales Record in July 2025; Gross Margin Reaches 31% Target One Quarter Early Newsmakers
[ September 4, 2025 ] Worksport (NASDAQ: WKSP) Posts Q2 2025 Results: Gross Profit Increases 173%, Revenue Jumps 83%, Margin Expands 870 bps, Operating Loss Improves 15% [QoQ]. Newsmakers

Celyad (NASDAQ: CYAD) CEO Christian Homsy shares his vision for universal CAR-T

March 19, 2018 admin Comments Off

Celyad (NASDAQ: CYAD) CEO Christian Homsy shares his vision for universal CAR-T

How to Trade Biotech and Pharmaceutical Stocks

March 11, 2018 admin Comments Off

How to Trade Biotech and Pharmaceutical Stocks Profiting from the FDA approval cycle

Exelixis (NASDAQ: EXEL) CEO Michael Morrissey gives an update on cabozantinib

March 10, 2018 admin Comments Off

Exelixis (NASDAQ: EXEL) CEO Michael Morrissey gives an update on cabozantinib

Picking Biotech Stocks in the Trump Era

February 7, 2018 admin Comments Off

Acura Pharmaceuticals Announces Successful Results from Study AP-LTX-301

January 10, 2018 admin Comments Off

PALATINE, Ill., Jan 08, 2018 -Acura Pharmaceuticals, Inc. (OTC QB: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that topline results from clinical study AP-LTX-301 (Study 301) for its LIMITx(TM) excess oral […]

Acura Pharmaceuticals, Inc (NASDAQ:ACUR) CEO Interview

November 26, 2012 admin Comments Off

Acura Pharmaceuticals, Inc (NASDAQ:ACUR)
Interview with Bob Jones, CEO […]

No Picture

Fluoro Pharma Medical (OTCBB:FPMI) CEO Interview

November 26, 2012 admin Comments Off

Fluoro Pharma Medical (OTCBB:FPMI)
Interview with Thijs Spoor, CEO and Chairman […]

CardioComm Solutions (TSX.V:EKG) CEO Interview

February 9, 2012 admin Comments Off

CardioComm Solutions (TSX.V:EKG) CEO: Etienne Grima […]

CEO Interview

StemCells, Inc (NASDAQ:STEM) CEO Interview

September 23, 2011 admin Comments Off

StemCells, Inc (NASDAQ:STEM)
Interview with Martin McGlynn, Ceo […]

REVA Medical (ASX:RVA) CEO Interview

September 16, 2011 admin Comments Off

REVA Medical (ASX:RVA)
Interview with Bob Stockman, Ceo […]

CEO Interview

IsoRay, Inc. (AMEX: ISR) CEO Interview

October 13, 2010 admin Comments Off

IsoRay, Inc. (AMEX: ISR)
Interview with Dwight Babcock, Chairman and CEO […]

Long-Term Contract in Place for Safety Syringe Platform: Revolutions Medical

September 9, 2010 admin Comments Off

Revolutions Medical Corp (OTC BB: RMCP)
Interview with Ron Wheet, CEO […]

Cardiogenesis Corporation: Positive Results from STAR-Heart Study

September 3, 2010 admin Comments Off

Cardiogenesis Corporation (OTC QB: CGCP)
Interview with Paul J. McCormick, Executive Chairman […]

Advent Technologies (NASDAQ: ADN) Announces Major Milestone in its Strategic Collaboration with Airbus

September 10, 2025 Comments Off on Advent Technologies (NASDAQ: ADN) Announces Major Milestone in its Strategic Collaboration with Airbus
Hoth Therapeutics (NASDAQ: HOTH) Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities

September 10, 2025 Comments Off on Hoth Therapeutics (NASDAQ: HOTH) Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities
Worksport (NASDAQ: WKSP) Posts Fourth Consecutive Monthly Sales Record in July 2025; Gross Margin Reaches 31% Target One Quarter Early

September 10, 2025 Comments Off on Worksport (NASDAQ: WKSP) Posts Fourth Consecutive Monthly Sales Record in July 2025; Gross Margin Reaches 31% Target One Quarter Early
Worksport (NASDAQ: WKSP) Posts Q2 2025 Results: Gross Profit Increases 173%, Revenue Jumps 83%, Margin Expands 870 bps, Operating Loss Improves 15% [QoQ].

September 4, 2025 Comments Off on Worksport (NASDAQ: WKSP) Posts Q2 2025 Results: Gross Profit Increases 173%, Revenue Jumps 83%, Margin Expands 870 bps, Operating Loss Improves 15% [QoQ].
Hoth Therapeutics’ (NASDAQ: HOTH) Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards

September 4, 2025 Comments Off on Hoth Therapeutics’ (NASDAQ: HOTH) Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards
Aditxt’s (NASDAQ: ADTX) Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030

August 28, 2025 Comments Off on Aditxt’s (NASDAQ: ADTX) Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030

“Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP)

September 15, 2025 Comments Off on “Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP)
Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business

September 15, 2025 Comments Off on Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business
NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market

September 15, 2025 Comments Off on NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market
Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL!

September 15, 2025 Comments Off on Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL!

“Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP)

September 15, 2025 Comments Off on “Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP)
Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business

September 15, 2025 Comments Off on Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business
NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market

September 15, 2025 Comments Off on NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market
Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL!

September 15, 2025 Comments Off on Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL!

Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.